These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 10362786)

  • 41. Alport syndrome: abnormalities of type IV collagen genes and proteins.
    Kashtan CE
    Ren Fail; 2000 Nov; 22(6):737-49. PubMed ID: 11104161
    [No Abstract]   [Full Text] [Related]  

  • 42. New approaches to the DNA diagnosis of Alport syndrome.
    Renieri A; De Marchi M
    Contrib Nephrol; 1996; 117():183-97. PubMed ID: 8801046
    [No Abstract]   [Full Text] [Related]  

  • 43. Transfer of the alpha 5(IV) collagen chain gene to smooth muscle restores in vivo expression of the alpha 6(IV) collagen chain in a canine model of Alport syndrome.
    Harvey SJ; Zheng K; Jefferson B; Moak P; Sado Y; Naito I; Ninomiya Y; Jacobs R; Thorner PS
    Am J Pathol; 2003 Mar; 162(3):873-85. PubMed ID: 12598321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha 5 COLIV chain distribution in glomerular basement membrane in a male with X-linked Alport syndrome and thin basement membrane.
    Rizzoni G; Massella L; Muda AO
    Pediatr Nephrol; 2000 Dec; 15(3-4):325. PubMed ID: 11149132
    [No Abstract]   [Full Text] [Related]  

  • 45. Molecular genetics of basement membranes: the paradigm of Alport syndrome.
    Antignac C
    Kidney Int Suppl; 1995 Jun; 49():S29-33. PubMed ID: 7674589
    [No Abstract]   [Full Text] [Related]  

  • 46. An unusual cause of pseudoachalasia: the Alport syndrome-diffuse leiomyomatosis association.
    Sousa RG; Figueiredo PC; Pinto-Marques P; Meira T; Novais LA; Vieira AI; Luz C; Borralho P; Freitas J
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1352-7. PubMed ID: 23765124
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrasound: a helpful diagnostic tool in esophageal leiomyomatosis with Alport syndrome.
    Denne C; Hahn H; Steinborn M; Hosie S; Lenz JC; Höpner F; Burdach S
    Ultraschall Med; 2011 Jun; 32(3):311-2. PubMed ID: 20614415
    [No Abstract]   [Full Text] [Related]  

  • 48. [Diffuse esophageal leiomyomatosis. Apropos of 5 cases with 2 familial cases].
    Leborgne J; Le Neel JC; Heloury Y; Audoin AF; David A; Babut JM; Lenne Y
    Chirurgie; 1989; 115(4-5):277-85; discussion 286. PubMed ID: 2612274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 7-Year-Old Boy With Alport Syndrome and Vomiting.
    Hinshaw A; El-Baba M
    Gastroenterology; 2018 Aug; 155(2):e15-e16. PubMed ID: 29409873
    [No Abstract]   [Full Text] [Related]  

  • 50. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome.
    Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG
    Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys.
    Heidet L; Cai Y; Guicharnaud L; Antignac C; Gubler MC
    Am J Pathol; 2000 Jun; 156(6):1901-10. PubMed ID: 10854213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alport syndrome with type I membranoproliferative glomerulonephritis.
    Meroni M; Sessa A; Battini G; Torri Tarelli L; Bertani T; Renieri A; Seri M; De Marchi M
    Nephron; 1993; 65(3):479-80. PubMed ID: 8290008
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical and molecular diagnosis of Alport syndrome.
    Kashtan CE
    Proc Assoc Am Physicians; 1995 Oct; 107(3):306-13. PubMed ID: 8608415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of alpha5(IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome.
    Nakanishi K; Iijima K; Kuroda N; Inoue Y; Sado Y; Nakamura H; Yoshikawa N
    J Am Soc Nephrol; 1998 Aug; 9(8):1433-40. PubMed ID: 9697665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crescentic and necrotising glomerulonephritis: a rare histological manifestation of Alport syndrome.
    Moyano Crespo GD; Torres AI; Mukdsi JH
    J Clin Pathol; 2015 Jul; 68(7):581-3. PubMed ID: 25869794
    [No Abstract]   [Full Text] [Related]  

  • 56. Alport syndrome. A review of the ocular manifestations.
    Colville DJ; Savige J
    Ophthalmic Genet; 1997 Dec; 18(4):161-73. PubMed ID: 9457747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variability of clinical phenotype in a large Alport family with Gly 1143 Ser change of collagen alpha 5(IV)-chain.
    Renieri A; Meroni M; Sessa A; Battini G; Serbelloni P; Torri Tarelli L; Seri M; Galli L; De Marchi M
    Nephron; 1994; 67(4):444-9. PubMed ID: 7969679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LINE-1 elements at the sites of molecular rearrangements in Alport syndrome-diffuse leiomyomatosis.
    Segal Y; Peissel B; Renieri A; de Marchi M; Ballabio A; Pei Y; Zhou J
    Am J Hum Genet; 1999 Jan; 64(1):62-9. PubMed ID: 9915944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distribution of the alpha 1 and alpha 2 chains of collagen IV and of collagens V and VI in Alport syndrome.
    Kashtan CE; Kim Y
    Kidney Int; 1992 Jul; 42(1):115-26. PubMed ID: 1635341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Animal models of Alport syndrome: advancing the prospects for effective human gene therapy.
    Heikkilä P; Tryggvason K; Thorner P
    Exp Nephrol; 2000; 8(1):1-7. PubMed ID: 10644876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.